Comparison 7. Subgroup analysis of NON‐endometriod cancer (clear and serous).

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Death from any cause (HR) for subgroup serous/clear cell	2		Hazard Ratio (Random, 95% CI)	0.98 [0.68, 1.40]
2 Death or recurrence (HR) for subgroup serous/clear cell cancer	2		Hazard Ratio (Random, 95% CI)	0.84 [0.57, 1.23]